1. <span id="izpls"></span>

    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    "One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    Boji Medical Technology Co., Ltd.
    Boji Medical Technology Co., Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
    SMO
    Consulting Service
    Consulting Service

    For more questions, please click "Consult Now", a professional consultant will answer your questions.

    Shanghai Pharmacies Medical & Biotechnology Co., Ltd. is a professional SMO company (SMO means site management organization). Founded in 2011, our company is located in Zhangjiang Hi-TechPark, Pudong, Shanghai. The founding team members and the company's technicians graduated from well-known universities at home and abroad with extensive clinical practical experience and management experience. We aim to provide professional services for clinical trials, assist researchers and research institutions in non-medical judgmental clinical work, improve the quality and progress of clinical trials and promote the standardization of clinical trials.




    The Clinical Coordination Department in Pharmacies established offices in more than 40 cities over the years, such as East China, South China, Central China, North China and Southwest China in Shanghai, Beijing, Guangzhou, Zhengzhou, Changsha, Harbin, Hangzhou, Wenzhou, Haikou, Xining, Kunming, Chongqing and Chengdu with nearly 200 CRC personnel. Following the ICH-GCP and the medical ethical principle of Helsinki Declaration, Pharmacies has established an international standard operating procedure (SOP).


    Over the years, the SMO Department has promoted development with high-quality. We firmly believe that quality is the concept of life. With fair price and efficient service, we have established long-term strategic partnership with our customers. Pharmacies have been highly recognized in the industry.


       




    To be continued....





    Pharmacies has participated in more than 300 projects, about 60 multi-center clinical studies and more than 200 research centers participating in the service. The majors involved are clinical, oncology, endocrinology, cardiovascular,respiratory, digestive, neuropsychiatric and infectious diseases, pediatrics, ophthalmology, orthopedics.
















    Pharmacies’ project covers various fields such as traditional Chinese medicine, chemical medicine, biological products, medical equipment, diagnostic reagents, etc. In recent years, multi-center clinical equipment projects have been increasing year by year and a relatively mature phase I clinical research service system has been formed.




    Examples of multi-center projects by early 2020


    Indication

    Project Type

    Project Stage

    Number of Centers

    Type 2 diabetes

    Chemical Medicine

    Stage IV

    >20

    Aged unstable angina

    Chinese Medicine

    Stage IV

    >25

    Cerebral infarction

    Chemical Medicine

    Stage IV

    >10

    Anemia due to chemotherapy for non-bone malignant tumors

    Biological Product

    Stage

    >15

    Aortic dissectionInstrumentStage

    >15

    Anemia due to chemotherapy for non-bone malignant tumors

    Biological product

    Stage

    >10

    Anemia due to chemotherapy for non-bone malignant tumors

    Biological product

    Stage

    >10

    Peptic ulcer

    Chemical Medicine

    Stage

    >10

    Knee osteoarthritis

    Chinese Medicine

    Stage

    >5

    Myelody splastic syndrome

    Chemical Medicine

    Stage IV

    >5

    Multi-drug resistant pulmonary tuberculosis with positive sputum culture

    Chemical Medicine

    Stage IV

    >25

    thrombosis

    Instrument

    Stage

    >20

    Anemia due to chemotherapy for non-bone malignant tumors

    Biological product

    Stage

    >5

    Oral ulcer

    Chinese Medicine

    Stage IV

    >5

    Primary glaucoma

    Instrument

    Stage

    >5

    Chronic hepatitis BChemical Medicine

    Stage

    >15

    Thalassemia pregnant womenChinese Medicine

    Stage IV

    >5

    common cold

    Chinese Medicine

    Stage

    >5

    Rheumatoid arthritis

    Chinese Medicine

    Stage

    >10

    Peptic ulcer bleedingChemical Medicine

    Stage

    >5

    Duodenal ulcer

    Chemical Medicine

    Stage

    >10

    Duodenal ulcer

    Chemical Medicine

    Stage

    >5

    Intracranial cerebral aneurysm

    Instrument

    Stage

    >10

    Acute exacerbation of chronic obstructive pulmonary diseaseInstrumentStage

    >10





    • Phone:400-0020-628
    • Address:Clinical Center:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou / Laboratory Address:No.62,Nanxiang One Road,Huangpu Disrict,Guangzhou
    Copyright ? Boji Medical Technology Co., Ltd. All Rights Reserved 粵ICP備13039920號 (粵)—非經營性—2020-0084 Powered by vancheer
    Copyright ? Boji Medical Technology Co., Ltd. All Rights Reserved 粵ICP備13039920號 (粵)—非經營性—2020-0084 Powered by vancheer
    JAPAN18XXXXHD VIDEOS日本